Pfizer Files 2024 10-K Report

Ticker: PFE · Form: 10-K · Filed: Feb 27, 2025 · CIK: 78003

Pfizer Inc 10-K Filing Summary
FieldDetail
CompanyPfizer Inc (PFE)
Form Type10-K
Filed DateFeb 27, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-K, annual-report, pharmaceuticals

TL;DR

Pfizer's 2024 10-K is in: full financial picture for the year ending Dec 31, 2024.

AI Summary

Pfizer Inc. filed its 2024 10-K report on February 27, 2025, detailing its financial performance for the fiscal year ending December 31, 2024. The company, headquartered at 66 Hudson Boulevard East, New York, NY, operates in the Pharmaceutical Preparations industry. The filing provides comprehensive financial statements, including the Consolidated Statements of Operations, and outlines key financial data and disclosures relevant to investors.

Why It Matters

This 10-K filing provides a detailed look at Pfizer's financial health and operational performance for the past fiscal year, offering crucial insights for investors and stakeholders.

Risk Assessment

Risk Level: medium — The filing is a standard annual report and does not inherently indicate new or elevated risks.

Key Numbers

  • 2834 — SIC Code (Standard Industrial Classification for Pharmaceutical Preparations)
  • 135315170 — IRS Number (Company's IRS identification number)

Key Players & Entities

  • Pfizer Inc. (company) — Filer of the 10-K report
  • 20241231 (date) — Fiscal year end date
  • 20250227 (date) — Filing date
  • 66 Hudson Boulevard East, New York, NY 10001-2192 (address) — Company business and mailing address

FAQ

What is the primary business of Pfizer Inc. according to this filing?

Pfizer Inc. is classified under the Standard Industrial Classification code 2834, which pertains to Pharmaceutical Preparations.

When was this 10-K report filed with the SEC?

This 10-K report was filed on February 27, 2025.

What fiscal period does this 10-K report cover?

The report covers the fiscal year ending December 31, 2024.

Where is Pfizer Inc. headquartered?

Pfizer Inc.'s business and mailing address is 66 Hudson Boulevard East, New York, NY 10001-2192.

What is the SEC file number for this filing?

The SEC file number for this filing is 001-03619.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on February 27, 2025 regarding PFIZER INC (PFE).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.